93.35
10.79 (13.07%)
| Penutupan Terdahulu | 82.56 |
| Buka | 86.76 |
| Jumlah Dagangan | 1,809,828 |
| Purata Dagangan (3B) | 564,659 |
| Modal Pasaran | 9,896,686,592 |
| Harga / Pendapatan (P/E Ke hadapan) | 238.10 |
| Harga / Jualan (P/S) | 15.59 |
| Harga / Buku (P/B) | 8.79 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 20 Feb 2025 - 24 Feb 2025 |
| Margin Keuntungan | -14.07% |
| Margin Operasi (TTM) | -22.15% |
| EPS Cair (TTM) | -0.870 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 39.00% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1.55% |
| Nisbah Semasa (MRQ) | 7.66 |
| Aliran Tunai Operasi (OCF TTM) | -62.16 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -6.95 M |
| Pulangan Atas Aset (ROA TTM) | -7.45% |
| Pulangan Atas Ekuiti (ROE TTM) | -9.90% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Bercampur |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Bercampur | |
| Stok | Intra-Cellular Therapies Inc. | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | 1.5 |
| Volatiliti Harga | -3.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 2.0 |
| Purata | 0.40 |
|
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 2.33% |
| % Dimiliki oleh Institusi | 96.14% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 100.00 (Needham, 7.12%) | Pegang |
| Median | 94.50 (1.23%) | |
| Rendah | 89.00 (JP Morgan, -4.66%) | Beli |
| Purata | 94.50 (1.23%) | |
| Jumlah | 1 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 90.52 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Needham | 13 Jan 2025 | 100.00 (7.12%) | Pegang | 94.87 |
| 31 Oct 2024 | 100.00 (7.12%) | Beli | 84.75 | |
| JP Morgan | 04 Nov 2024 | 89.00 (-4.66%) | Beli | 86.17 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |